Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

No increased risk of childhood cancer near UK nuclear sites, study finds

2.

How the skin cancer virus outperforms the replication of host cells.

3.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer

4.

Adding Isatuximab to Standard Backbone Prolongs PFS in Myeloma

5.

Early Identification of Ovarian Cancer; Allergy Medicine for NSCLC? Unfavorable Development for Anti-TIGIT Medication?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot